Inactive Instrument

Think Research Corporation

THNK

CA88410J1075

Think Research Corporation Reports Earnings Results for the Full Year Ended December 31, 2022

May 01, 2023 at 05:08 pm IST

Think Research Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CAD 78.6 million compared to CAD 47.79 million a year ago. Net loss was CAD 25.74 million compared to CAD 29.05 million a year ago.

Basic loss per share from continuing operations was CAD 0.42 compared to CAD 0.62 a year ago. Diluted loss per share from continuing operations was CAD 0.42 compared to CAD 0.62 a year ago.

Latest news about Think Research Corporation

Healwell AI Inc. agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.	13/06	CI
Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders.	18/04	CI
Transcript : Think Research Corporation - Shareholder/Analyst Call	04/04
Think Research Says No Alternative Buyers Emerge as Shareholder Vote Next Week on Going Private Transaction	27/03	MT
Think Research Brief: Co Says "Now subject to a non-solicitation covenant with customary "fiduciary out" provisions Under Terms of the Arrangement Agreement	27/03	MT
Think Research Brief: Providing Update on Going Private Transaction; "Go-shop" Period Expired on March 16, 2024, With No Acquisition Proposal Having Been Received	27/03	MT
Think Research Corp. Provided a Financial Update	06/03	MT
Think Research Announces $5.0 Million Contract Expansion with a Global Pharmaceutical Company	22/02	CI
Think Research Agrees to be Bought by Beedie Capital; Up 87.5%	16/02	MT
Think Research Agrees to be Bought by Beedie Capital	16/02	MT
Think Research Brief: Shareholders to receive cash payment of $0.32 per Common Share	16/02	MT
Think Research Brief: Entering into Definitive Agreement to be Acquired by Beedie Capital	16/02	MT
Beedie Capital entered into an arrangement agreement to acquire remaining stake in Think Research Corporation (TSXV : THNK) from shareholders.	16/02	CI
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility; Up 7%	20/01	MT
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility	19/01	MT
Think Research's Learning Management System to Support Healthcare Professional Education and Training	08/12	CI
Transcript : Think Research Corporation, Q3 2023 Earnings Call, Nov 27, 2023	27/11
Think Research Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/11	CI
Think Research Corporation Appoints Jeffrey Orridge to Its Board of Directors	21/23/21	CI
Major Long-Term Care Pharmacy Selects Think Research Corporation's Pharmapod to Enhance Medication Safety	06/23/06	CI
Think Research Announces Agreement For Advance Under Convertible Facility	29/23/29	MT
Think Research Corporation Announces Technology Partner Supporting Ontario Ministry of Health's One Stop Talk/Parlons Maintenant Service for Child and Youth Mental Health	12/23/12	CI
Think Research Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Transcript : Think Research Corporation, Q2 2023 Earnings Call, Aug 29, 2023	29/23/29
Think Research Corporation Announces Bridge Loan	18/23/18	CI

Chart Think Research Corporation

Duration

Period

More charts

Company Profile

Think Research Corporation is a Canada-based company engaged in delivering knowledge-based digital health software solutions. The Companyâs evidence-based healthcare technology solutions support the clinical decision-making process and standardization of care to facilitate better health care outcomes. It gathers, develops, and delivers knowledge-based solutions globally to customers, including enterprise clients, hospitals, health regions, healthcare professionals, and / or governments. The Company licenses its solutions to over 14,200 facilities for over 320,000 primary care, acute care, and long-term care doctors, nurses and pharmacists that rely on the content and data provided by the Company to support their practices. In addition, the Company collects and manages pharmaceutical and clinical trial data via its BioPharma Services subsidiary. The Companyâs other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery.

Sector

Software

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Software

	1st Jan change	Capi.
MICROSOFT CORPORATION	+18.86%	3,366B
SYNOPSYS INC.	+15.57%	91.16B
CADENCE DESIGN SYSTEMS, INC.	+12.99%	84.42B
PALANTIR TECHNOLOGIES INC.	+47.52%	56.16B
DASSAULT SYSTÈMES SE	-20.20%	49.25B
THE TRADE DESK, INC.	+35.77%	48.04B
ATLASSIAN CORPORATION	-25.64%	45.03B
SEA LIMITED	+76.35%	42.79B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-3.39%	27.47B

Other Software